Premium
Drug survival of secukinumab for moderate‐to‐severe plaque psoriasis: reply from authors
Author(s) -
Egeberg A.,
Skov L.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.16690
Subject(s) - secukinumab , plaque psoriasis , medicine , dermatology , drug , psoriasis , pharmacology , psoriatic arthritis
Linked Article: Egeberg et al. Br J Dermatol 2018; 178 :509–19.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom